Regenerative Biotechnology

CTM Biodent Gingiva

Injectable solution with mesenchymal stem cells for regeneration of affected gingival tissue.

A product based on placenta-derived mesenchymal stem cells that promotes gingival tissue regeneration and restoration of damaged periodontal structures.
View technical sheet

Composition

Mesenchymal stem cells derived from placenta.

Pharmaceutical form

Injectable solution.

Presentation

Monovette plástico con 1 ml, 5 millones de células.

Therapeutic properties

Promotes gingival regeneration through release of trophic factors with antiapoptotic, antifibrotic, angiogenic, and mitotic effects, while modulating local immune response.
  • Gingival tissue regeneration.
  • Immune system modulation.
  • Local angiogenic stimulation.
  • Reduction of periodontal inflammation.
  • Periodontal ligament repair.
  • Root cementum regeneration.
  • Alveolar bone regeneration.
  • Improvement of periodontal condition.

Mechanism of action & Clinical data

Release of trophic factors and extracellular vesicles that modulate inflammation, immune response, and promote periodontal tissue regeneration.

Indications

Gingival tissue regeneration in loss or recession due to periodontal disease, trauma, or surgical interventions.

Administration

Intraginigival application via injection into free or marginal gingiva by trained professional, at 4–6 week intervals.

Contraindications

Hypersensitivity to any component of the formula and diagnosis of neoplasia.

Storage

Refrigerate between 2–8 °C, protect from light, do not freeze, administer within 24 hours after reception.
*Product for exclusive use by healthcare professionals. Application under medical protocols only.

I want to be contacted

    CTM Biodent Gingiva